Why start treatment with levodopa? - Cure Parkinson's

Cure Parkinson's

26,583 members27,900 posts

Why start treatment with levodopa?

grey profile image
grey
7 Replies

I was diagnosed in the dopamine agonist era, treatment to start with agonists, supplemented with MAOb inhibitor. The aim was to delay taking levodopa as long as possible which in turn would delay onset of motor fluctuations and dyskinesia.

Inevitably, the loss of dopamine was not matched by agonist and MAOb, and then levodopa was introduced. In many cases, agonists side effects became significant and levodopa was introduced at an earlier stage so agonist could be reduced to level low enough to prevent adverse side effects, but still have therapeutic value.

We were encouraged to delay starting levodopa, and stick to our daily schedule as there was strong evidence that future motor complications would be brought on earlier and / or be more troublesome. Same applied to dyskinesia. We were faced with a simple decision; do I delay starting levodopa which will result in a lower quality of life now but will give me a higher quality in the future, or do I go for it now and the future will take care of itself.

It has been observed that in recent times many newly diagnosed are started on levodopa monotherapy. This goes against the advice many of us received. Why the change? And if agonists are not to be used, why not start with MAOb inhibitors?

Could this be the answer?

Summary report in Science Daily:

sciencedaily.com/releases/2...

More detailed report in The Lancet:

thelancet.com/journals/lanc...

-------------------

Revision - added link to The Lancet article

Written by
grey profile image
grey
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Leilani23 profile image
Leilani23

Thanks for posting this, Grey. I printed it out and will refer to it when the time comes for me to be medicated.

Leilani

grey profile image
grey in reply toLeilani23

Leilani, it's would be interesting to hear from you the initial advice you were given on medication.

Useful if you could add country, date of diagnosis and who advised you (neurologist, GP, Parkinson Nurse, etc.)

Indeed, if anyone diagnosed in past couple of years wishes to add their initial medication advice then please do.

Pete-1 profile image
Pete-1

Preliminary results from a large scale trial (PubMed - I think that is where I heard this from) indicate that using Levodopa early in treatment has no effect on disease progression. Problems seen with Levodopa are resultant from PD progression rather than PD progression being due to treatment by Levodopa.

grey profile image
grey in reply toPete-1

Pete,

I've added reference to The Lancet article about this research. Full report free!

Pete-1 profile image
Pete-1 in reply togrey

grey,

Thanks for the notice of the Lancet article rergrding the PubMed trial.

Balderdash profile image
Balderdash

The SELEDO ( selegieine-levadopa) study was carried out as a multicenter long-term, 5-year trial to evaluate the possible advantages of combining selegiline and levodopa in the early treatment of Parkinson's disease.116 patients were recruited and the study revealed that the early combination of selegiline and levodopa was clearly superior to levodopa monotherapy.

1999 Lippincott Williams & Wilkins.

TheHealingProject profile image
TheHealingProject

My journey is the same as yours, but I was diagnosed at 50 and am 55 now. Experimenting with Levadopa now (NOT Sinamet). Cutting down the agonist (Mirapex .25mg/day) now. I use 200mg Amantadine a day with Selegeline (10mg/day). Never was on Sinemet, but found a product called Dopaboost which has worked - depending on what I ate beforehand.

Not what you're looking for?

You may also like...

Risk of long-term levodopa/carbidopa side effects

I recently came across an article produced by the Cleveland Clinic which was an eye-opener. It said...

Dihydroergocryptine

Dihydroergocryptine (DHEC, trade names Almirid, Cripar) is a dopamine agonist of the ergoline...
Farooqji profile image

LEVODOPA VERDICT: Start Early/Late = Same Outcomes

"Doctors often delay prescribing levodopa, or L-dopa, to Parkinson's patients for fear that the...

Phase 3 Positive Topline Results for Tavapadon

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial...
nednedned profile image

Have you ever suffered a dopamine agonist trigger persistent OH? (orthostatic hypotension: low blood pressure / dizzyness upon standing)

After 2 weeks of a low dosage of a dopamine agonist, I got OH - I suddenly became unable to stand...
park_bear profile image

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.